In The News Posted January 15, 2019 Share Posted January 15, 2019 BOSTON, Jan. 15, 2019 /PRNewswire/ -- Life Biosciences has announced the closing of a Series B financing round of $50 million, according to Tristan Edwards, chief executive officer and co-founder. The Company initially targeted a $25 million round but upsized to meet investor demand. The... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.